The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome

This publication has 51 references indexed in Scilit:

• The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model
  Life Sciences, 2013
• Rimonabant: From RIO to Ban
  Journal of Obesity, 2011
• Genetic modifiers of neurological disease
  Current Opinion in Genetics & Development, 2011
• Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
  Nature Neuroscience, 2010
• Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects
  The Journal of Physiology, 2010
• Characterization of Monoacylglycerol Lipase Inhibition Reveals Differences in Central and Peripheral Endocannabinoid Metabolism
  Chemistry & Biology, 2009
• Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
  Nature Chemical Biology, 2008
• The orphan receptor GPR55 is a novel cannabinoid receptor
  British Journal of Pharmacology, 2007
• The general anesthetic propofol increases brain N‐arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase
  British Journal of Pharmacology, 2003
• Brain Regional Distribution of Endocannabinoids: Implications for Their Biosynthesis and Biological Function
  Biochemical and Biophysical Research Communications, 1999